Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipo-PGE1 PK for VOD Prevention in HSCT
NCT02338440Phase 3Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2015
- Primary completion
- Dec 2019
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of lipoprostaglandin E1 in veno-occlusive disease (SOS), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
lipoprostaglandin E1
03
Conditions
veno-occlusive disease (SOS)
Beyond the preview
Go deeper on NCT02338440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02338440.